CHD1Li 6.11, CAS 2716890-91-2

Product Description: CHD1Li 6.11 is a potent oncogenic CHD1L inhibitor (IC50=3.3 µM for cat-CHD1L recombinant protein). CHD1Li 6.11 is an orally bioavailable antitumor agent, significantly reducing the tumor volume of CRC xenografts generated from isolated quasi mesenchymal cells (M-phenotype), which possess enhanced tumorigenic properties[1].

Applications: Cancer-programmed cell death

Formula: C21H22BrN5OS

References: [1]Prigaro BJ, et al. Design, Synthesis, and Biological Evaluation of the First Inhibitors of Oncogenic CHD1L. J Med Chem. 2022;65(5):3943-3961.

CAS Number: 2716890-91-2

Molecular Weight: 472.40

Compound Purity: 99.54

Research Area: Cancer

Solubility: DMSO : 100 mg/mL (ultrasonic)

Target: DNA/RNA Synthesis

• Artikelnummer: MEXHY-144256-10.1
• Hersteller: MedChemExpress
• Hersteller Artikelnummer: HY-144256-10.1
• Verpackungseinheit: 10mM/1mL
• Mengeneinheit: STK